Statistics for ACADIA Pharmaceuticals (id:7451 ACAD)

Valuation metrics

Market cap

2.69B

Enterprise value

2.19B

Trailing P/E (ttm)

20.74

Forward P/E

19.73

PEG ratio

19.73

Price/Sales (ttm)

2.90

Price/Book (mrq)

4.66

Enterprise Value/Revenue

2.36

Enterprise Value/EBITDA

17.59

Overview

Shares outstanding

166.39M

Float

108.97M

Shares short

9.53M

% Held by insiders

0.01%

% Held by institutions

0.97%

Average volume (10 days)

1.35M

Average volume (90 days)

Price summary

52-Week low

14.15

52-Week high

32.59

52-Week change

-35.12%

Beta

0.38

50-Day moving average

15.61

200-Day moving average

17.34

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

13.83%

Operating margin

12.64%

Operational effectiveness

Return on assets

8.72%

Return on equity

27.36%

Income statement

Revenue (ttm)

5.62

Revenue per share (ttm)

5.62

Quarterly revenue growth (yoy)

Gross profit (ttm)

684.80M

EBITDA

124.54M

Net income to common (ttm)

128.51M

Diluted EPS (ttm)

0.78

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

565.33M

Total cash per share (mrq)

3.40

Total debt (mrq)

49.37M

Total Debt/Equity (mrq)

8.55

Current ratio (mrq)

229.20%

Book value per share (mrq)

3.47

Cash flow

Cash flow statement

202.73M

Levered free cash flow (LFCF)

221.72M